Interestingly, miR-302a/b/c/d has been shown to reverse the MDR phenotype in BC cells by indirectly repressing P-gp following Mitogen-activated protein kinase kinase kinase 1 (MEKK1) targeting in the extracellular-signal-regulated kinase (ERK) pathway [25]. This evidence concerns the gene MAP3K1 and breast cancer.